AMRX — AMNEAL PHARMACEUTICALS INC

Ownership history in TPG GP A, LLC · 17 quarters on record

This page tracks every 13F SEC filing in which TPG GP A, LLC reported a position in AMNEAL PHARMACEUTICALS INC (AMRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

6.72% (2025 Q3)

Avg. % of fund

1.93%

First filed

2021 Q4

Last filed

2025 Q4

Quarters held

17

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	UNCHANGED	12,328,767	—	0%	5.78%	$155.3M	$12.60
2025 Q3	UNCHANGED	12,328,767	—	0%	6.72%	$123.4M	$10.01
2025 Q2	UNCHANGED	12,328,767	—	0%	5.32%	$99.7M	$8.09
2025 Q1	UNCHANGED	12,328,767	—	0%	2.04%	$103.3M	$8.38

% of Fund (quarterly) AMRX price (monthly, adj. close)

Other funds also holding AMRX

As of 2025 Q4 — sorted by position size

Westshore Wealth, LLC 3Y 5.76% Phocas Financial Corp. 3Y 7Y 2.15% Rubric Capital Management LP 3Y 7Y 1.86% PFM Health Sciences, LP 3Y 7Y 1.84% BlackBarn Capital Partners LP 1.3% Nantahala Capital Management, LLC 3Y 7Y 1.02% Penn Capital Management Company, LLC 3Y 7Y 1.01% Jackson Creek Investment Advisors LLC 3Y 0.83% Informed Momentum Co LLC 3Y 7Y 0.6% Odyssean, LLC 0.53%

← Back to TPG GP A, LLC Holdings